HPR-18627-83815
2 vaccinations
1 coded response
9 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 941 / CA
- Registered
- 2021-11-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-08
Dose 1 — Janssen/Johnson & Johnson
-
2021-11-30
Registered in v-safe
-
2021-11-30
Dose 2 — Pfizer-BioNTech
-
2021-12-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-12-03
- 2021-12-04
- 2021-12-06
- 2021-12-07
- 2021-12-14
-
2022-01-04
Survey response — day 35, dose 2MedDRA: Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend schoolFree text: I have positive covid test. Running nose and sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-01-11
- 2022-03-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-08 | Janssen/Johnson & Johnson | No |
| 2 | 2021-11-30 | Pfizer-BioNTech | No |
Free text
Release 10 — day 35, dose 2
Symptoms: I have positive covid test. Running nose and sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release